Caricamento...
FDA Intensifies Drive to Reduce REMS Burdens: The Key Objective Is to Ease Workflow Obstacles for Pharmacists
The FDA is working to solve problems with the often-confusing risk evaluation and mitigation strategy program, which covers 74 pharmaceuticals and four drug classes. Issues include patient access to drugs and the dominant role of specialty pharmacies.
Salvato in:
| Pubblicato in: | P T |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MediMedia USA, Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4745637/ https://ncbi.nlm.nih.gov/pubmed/26909000 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|